Trial results
$IMVT — IMVT-1402
Immunovant, Inc. (IMVT) IMVT-1402: trial results in Graves' disease, myasthenia gravis, and chronic inflammatory demyelinating polyneuropathy, 2027.
The catalyst
"We expect to report top-line results from these trials in calendar year 2027."
— Immunovant, Inc., 10-Q filed 2026-11-09 · the filing. Checked word for word against the stored document when this page was built; a sentence that did not check out would not be here.
- Event id
IMVT-IMVT1402-2026- Company
- Immunovant, Inc.
- Kind
- Trial results
- Indication
- Graves' disease, myasthenia gravis, and chronic inflammatory demyelinating polyneuropathy
- Window
- 2027-01-01 – 2027-12-31
- Status
- dropped
The bar
No bar has been published for this event yet.
Verdicts
No verdict has been published for this event yet.